ArticleMedicine2020

Venetoclax + hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia: Two case reports.

Hongxia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.